KR0148748B1 - 사이클로스포린을 함유하는 약학조성물 - Google Patents

사이클로스포린을 함유하는 약학조성물

Info

Publication number
KR0148748B1
KR0148748B1 KR1019890013380A KR890013380A KR0148748B1 KR 0148748 B1 KR0148748 B1 KR 0148748B1 KR 1019890013380 A KR1019890013380 A KR 1019890013380A KR 890013380 A KR890013380 A KR 890013380A KR 0148748 B1 KR0148748 B1 KR 0148748B1
Authority
KR
South Korea
Prior art keywords
composition
cyclosporin
weight
phase component
surfactant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
KR1019890013380A
Other languages
English (en)
Korean (ko)
Other versions
KR900004348A (ko
Inventor
기트 호이어 비르
마인쩌 아르민
포산스키 울리히
리히터 프리드리히
Original Assignee
장 크라메르, 한스 루돌프 하우스
산도즈 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27264085&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR0148748(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB888821754A external-priority patent/GB8821754D0/en
Priority claimed from GB898902900A external-priority patent/GB8902900D0/en
Priority claimed from GB898902903A external-priority patent/GB8902903D0/en
Application filed by 장 크라메르, 한스 루돌프 하우스, 산도즈 리미티드 filed Critical 장 크라메르, 한스 루돌프 하우스
Publication of KR900004348A publication Critical patent/KR900004348A/ko
Priority to KR1019970011383A priority Critical patent/KR100235524B1/ko
Application granted granted Critical
Publication of KR0148748B1 publication Critical patent/KR0148748B1/ko
Priority to KR1019990019492A priority patent/KR100267149B1/ko
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Nanotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dispersion Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medical Informatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
KR1019890013380A 1988-09-16 1989-09-12 사이클로스포린을 함유하는 약학조성물 Expired - Lifetime KR0148748B1 (ko)

Priority Applications (2)

Application Number Priority Date Filing Date Title
KR1019970011383A KR100235524B1 (en) 1988-09-16 1997-03-29 Pharmaceutical compositions comprising cyclosporins
KR1019990019492A KR100267149B1 (ko) 1988-09-16 1999-05-28 사이클로스포린을 함유하는 약학 조성물

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB8821754 1988-09-16
GB888821754A GB8821754D0 (en) 1988-09-16 1988-09-16 Improvements in/relating to organic compounds
GB898902900A GB8902900D0 (en) 1989-02-09 1989-02-09 Improvements in or relating to organic compounds
GB898902903A GB8902903D0 (en) 1989-02-09 1989-02-09 Improvements in or relating to organic compounds
GB8902900 1989-02-09
GB8902903 1989-02-09

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1019970054119A Division KR100446170B1 (ko) 1988-09-16 1997-10-18 사이클로스포린을함유하는약학조성물

Publications (2)

Publication Number Publication Date
KR900004348A KR900004348A (ko) 1990-04-12
KR0148748B1 true KR0148748B1 (ko) 1998-08-17

Family

ID=27264085

Family Applications (3)

Application Number Title Priority Date Filing Date
KR1019890013380A Expired - Lifetime KR0148748B1 (ko) 1988-09-16 1989-09-12 사이클로스포린을 함유하는 약학조성물
KR1019970054119A Expired - Fee Related KR100446170B1 (ko) 1988-09-16 1997-10-18 사이클로스포린을함유하는약학조성물
KR1019990035661A Expired - Lifetime KR100894130B1 (ko) 1988-09-16 1999-08-26 사이클로스포린을 함유하는 약학 조성물

Family Applications After (2)

Application Number Title Priority Date Filing Date
KR1019970054119A Expired - Fee Related KR100446170B1 (ko) 1988-09-16 1997-10-18 사이클로스포린을함유하는약학조성물
KR1019990035661A Expired - Lifetime KR100894130B1 (ko) 1988-09-16 1999-08-26 사이클로스포린을 함유하는 약학 조성물

Country Status (32)

Country Link
US (7) US5741512A (enExample)
JP (1) JPH0725690B2 (enExample)
KR (3) KR0148748B1 (enExample)
AT (1) AT403435B (enExample)
AU (1) AU627220B2 (enExample)
BE (1) BE1003105A5 (enExample)
BG (1) BG60525B2 (enExample)
CA (1) CA1332150C (enExample)
CH (1) CH679118A5 (enExample)
DE (1) DE3930928C2 (enExample)
DK (1) DK171433B1 (enExample)
ES (1) ES2020738A6 (enExample)
FI (1) FI98046C (enExample)
FR (1) FR2636534B1 (enExample)
GB (1) GB2222770B (enExample)
GR (1) GR1000456B (enExample)
HK (1) HK86593A (enExample)
HU (1) HU211685A9 (enExample)
ID (1) ID17863A (enExample)
IE (1) IE60764B1 (enExample)
IL (1) IL91642A (enExample)
IT (1) IT1232243B (enExample)
LU (1) LU87586A1 (enExample)
LV (1) LV5749B4 (enExample)
MY (1) MY107381A (enExample)
NL (1) NL194781C (enExample)
NO (1) NO180362C (enExample)
NZ (1) NZ230660A (enExample)
PH (1) PH31059A (enExample)
PT (1) PT91731B (enExample)
SE (2) SE8903042L (enExample)
SG (1) SG50793G (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004073693A1 (en) * 2003-02-19 2004-09-02 Korea United Pharm, Inc. Soft capsule containing cyclosporine and it's manufacturing process
KR100894130B1 (ko) * 1988-09-16 2009-04-20 노바티스 아게 사이클로스포린을 함유하는 약학 조성물
WO2013055073A3 (ko) * 2011-10-10 2013-07-04 Kim Yong Nam 사이클로스포린 함유 안약 조성물 및 그 제조방법

Families Citing this family (182)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639724A (en) * 1984-07-24 1997-06-17 Sandoz Ltd. Cyclosporin galenic forms
US6007840A (en) * 1988-09-16 1999-12-28 Novartis Ag Pharmaceutical compositions comprising cyclosporins
GR1000466B (el) * 1989-01-28 1992-07-30 Sandoz Ag Μεθοδος παρασκευης νεων φαρμακευτικων μορφων κυκλοσπορινης.
FR2642650B1 (fr) * 1989-02-09 1994-12-09 Sandoz Sa Nouvelles compositions pharmaceutiques a base de cyclosporines
US7081445B2 (en) * 1989-02-20 2006-07-25 Novartis Ag Cyclosporin galenic forms
US4996193A (en) * 1989-03-03 1991-02-26 The Regents Of The University Of California Combined topical and systemic method of administration of cyclosporine
GB8916901D0 (en) 1989-07-24 1989-09-06 Sandoz Ltd Improvements in or relating to organic compounds
HU208491B (en) * 1990-11-27 1993-11-29 Gyogyszerkutato Intezet Process for producing oral pharmaceutical composition containing cyclosporin
CA2108266C (en) * 1991-04-19 2003-06-03 Albert J. Owen Convertible microemulsion formulations
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
GB9113872D0 (en) * 1991-06-27 1991-08-14 Sandoz Ag Improvements in or relating to organic compounds
AU688920B2 (en) * 1991-06-27 1998-03-19 Novartis Ag Transesterified corn oil products
IL102236A0 (en) * 1991-06-27 1993-01-14 Ltt Inst Co Ltd Topical preparations containing cyclosporin
GB9208712D0 (en) * 1992-04-22 1992-06-10 Sandoz Ltd Pharmaceutical compositions containing cyclosporin derivates
DK0642332T3 (da) * 1992-05-13 1997-06-16 Sandoz Ltd Ophthalmiske præparater indeholdende cyclosporin
ES2168271T3 (es) * 1992-09-25 2002-06-16 Novartis Ag Composiciones farmaceuticas que contienen ciclosporinas.
CA2161143A1 (en) † 1993-04-20 1994-10-27 Monika Fleck New pharmaceutical preparations comprising cyclosporin for oral administration
NZ247516A (en) * 1993-04-28 1995-02-24 Bernard Charles Sherman Water dispersible pharmaceutical compositions comprising drug dissolved in solvent system comprising at least one alcohol and at least one surfactant
CH686761A5 (de) * 1993-05-27 1996-06-28 Sandoz Ag Galenische Formulierungen.
GB2278780B (en) * 1993-05-27 1998-10-14 Sandoz Ltd Macrolide formulations
AT408520B (de) * 1993-05-27 2001-12-27 Novartis Erfind Verwalt Gmbh Galenische formulierungen
DE4447972B4 (de) * 1993-05-27 2007-12-27 Novartis Ag Galenische Formulierungen
DE4322826A1 (de) * 1993-07-08 1995-01-12 Galenik Labor Freiburg Gmbh Pharmazeutisches Präparat
GB2281697A (en) * 1993-09-14 1995-03-15 Euro Celtique Sa Laxative compositions in capsules
ATE198041T1 (de) * 1993-09-28 2000-12-15 Scherer Gmbh R P Herstellung von weichgelatinekapseln
GB2315216B (en) * 1993-10-05 1998-10-14 Ciba Geigy Ag Microemulsion preconcentrates comprising FK506 or 33-epi-chloro-33-desoxy-ascomycin
DE4340781C3 (de) * 1993-11-30 2000-01-27 Novartis Ag Cyclosporin enthaltende flüssige Zubereitungen und Verfahren zu ihrer Herstellung
KR0146671B1 (ko) * 1994-02-25 1998-08-17 김충환 사이클로스포린-함유 분말 조성물
GB9405304D0 (en) * 1994-03-16 1994-04-27 Scherer Ltd R P Delivery systems for hydrophobic drugs
US5447729A (en) * 1994-04-07 1995-09-05 Pharmavene, Inc. Multilamellar drug delivery systems
US5474979A (en) * 1994-05-17 1995-12-12 Allergan, Inc. Nonirritating emulsions for sensitive tissue
FI100692B (fi) * 1994-05-24 1998-02-13 Leiras Oy Menetelmä farmaseuttisten koostumusten valmistamiseksi, jolloin koostu mukset pohjautuvat mikroemulsiogeeleihin sekä uusia mikroemulsioihin p ohjautuvia geelejä
GB2308545B (en) * 1994-10-26 1999-06-02 Novartis Ag Pharmaceutical microemulsion preconcentrates
IL115742A (en) * 1994-10-26 2000-06-01 Novartis Ag Pharmaceutical compositions comprising a difficultly soluble active agent a hydrophilic phase a lipophilic phase and a surfactant
PT789580E (pt) 1994-11-03 2002-09-30 Novartis Ag Formulacoes de ciclosporina para administracao oral com composicao simples e alta biodisponibilidade e processo para a sua producao
US5603951A (en) * 1994-11-09 1997-02-18 Hanmi Pharm. Ind. Co., Ltd. Cyclosporin-containing soft capsule compositions
HU215966B (hu) * 1994-11-21 1999-07-28 BIOGAL Gyógyszergyár Rt. Orálisan alkalmazható, ciklosporint tartalmazó, összetett emulzió-előkoncentrátum
KR0167613B1 (ko) * 1994-12-28 1999-01-15 한스 루돌프 하우스, 니콜 케르커 사이클로스포린-함유 연질캅셀제 조성물
CA2221145A1 (en) * 1995-05-19 1996-11-21 Abbott Laboratories Self-emulsifying formulations of lipophilic drugs
US6696413B2 (en) * 1995-06-16 2004-02-24 Hexal Ag Pharmaceutical preparation with cyclosporin A
EP0760237A1 (en) * 1995-08-30 1997-03-05 Cipla Limited Oil-in-water microemulsions
DE19544507B4 (de) 1995-11-29 2007-11-15 Novartis Ag Cyclosporin enthaltende Präparate
NZ280689A (en) * 1995-12-15 1997-08-22 Bernard Charles Sherma Sherman Pharmaceutical composition comprising a cyclosporipharmaceutical composition comprising a cyclosporin; a tocol, tocopherol or tocotrienol; and propylen; a tocol, tocopherol or tocotrienol; and propylene carbonate or polyethylene glycol ne carbonate or polyethylene glycol
CZ288631B6 (cs) * 1996-01-18 2001-08-15 Galena, A. S. Léčivé přípravky s obsahem cyklosporinu
GB9601120D0 (en) * 1996-01-19 1996-03-20 Sandoz Ltd Organic compounds
US5858401A (en) 1996-01-22 1999-01-12 Sidmak Laboratories, Inc. Pharmaceutical composition for cyclosporines
US6245349B1 (en) * 1996-02-23 2001-06-12 éLAN CORPORATION PLC Drug delivery compositions suitable for intravenous injection
KR970064620A (ko) * 1996-03-05 1997-10-13 임성기 사이클로스포린-함유 외용약제 조성물
SE511313C2 (sv) 1997-01-13 1999-09-06 Gs Dev Ab Komposition med reglerad frisättning innefattande fettsyraester av diacylglycerol
KR20040004416A (ko) 1997-01-30 2004-01-13 노파르티스 아게 오일을 함유하지 않은 사이클로스포린 ａ 함유 제약 조성물
US6426078B1 (en) 1997-03-17 2002-07-30 Roche Vitamins Inc. Oil in water microemulsion
NZ502566A (en) 1997-07-29 2002-03-28 Upjohn Co Pharmaceutical composition for acidic lipophilic compounds in a form of a self-emulsifying formulation containing a pyranone and a basic amine
BR9810866B1 (pt) * 1997-07-29 2010-07-13 composição farmacêutica em uma forma de formulação auto-emulsificante para compostos lipofìlicos.
US6346511B1 (en) 1997-09-08 2002-02-12 Panacea Biotec Limited Pharmaceutical composition comprising cyclosporin
US6187747B1 (en) 1997-09-08 2001-02-13 Panacea Biotech Limited Pharmaceutical composition comprising cyclosporin
US6008191A (en) * 1997-09-08 1999-12-28 Panacea Biotec Limited Pharmaceutical compositions containing cyclosporin
DK0991660T3 (da) 1997-10-08 2006-02-13 Isotechnika Inc Deuterede og udeuterede cyclosporinanaloger og deres anvendelse som immunmodulerende midler
US20030220234A1 (en) * 1998-11-02 2003-11-27 Selvaraj Naicker Deuterated cyclosporine analogs and their use as immunodulating agents
US6063762A (en) * 1997-12-05 2000-05-16 Chong Kun Dang Corp. Cyclosporin-containing microemulsion preconcentrate composition
KR100300251B1 (ko) * 1997-12-05 2001-10-29 김용규 사이클로스포린함유약학적조성물
ID25908A (id) * 1998-03-06 2000-11-09 Novartis Ag Prakonsentrat-prakonsentrat emulsi yang mengandung siklosporin atau makrolida
GB2380674B (en) * 1998-03-06 2003-05-28 Novartis Ag Emulsion preconcentrates containing cyclosporin or a macrolide
AU759480B2 (en) 1998-07-01 2003-04-17 Debiopharm S.A. Novel cyclosporin with improved activity profile
EP0977180B1 (en) * 1998-07-30 2005-02-09 STMicroelectronics S.r.l. Method for assembling an actuator device for a hard disc device, comprising a read/write transducer, a microactuator and a suspension and the actuator device thus obtained
DE69822814T2 (de) * 1998-08-18 2005-01-27 Panacea Biotec Ltd. Zusammensetzung enthaltend Cyclosporin in einem hydrophilen Träger
SE9804192D0 (sv) * 1998-12-03 1998-12-03 Scotia Lipidteknik Ab New formulation
GB2344520A (en) * 1998-12-08 2000-06-14 Phares Pharm Res Nv Pharmaceutical carriers comprising lipids and polymers
CN1236813C (zh) 1998-12-11 2006-01-18 药品处理公司 水难溶性药物的自乳化组合物
DE19859910C2 (de) * 1998-12-23 2001-03-22 Ratiopharm Gmbh Orales Arzneimittel
DE69939335D1 (de) * 1998-12-30 2008-09-25 Dexcel Ltd Dispergierbares konzentrat zur verabreichung von cyclosporin
GB9903547D0 (en) * 1999-02-16 1999-04-07 Novartis Ag Organic compounds
US6267985B1 (en) * 1999-06-30 2001-07-31 Lipocine Inc. Clear oil-containing pharmaceutical compositions
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US6294192B1 (en) * 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US6057289A (en) * 1999-04-30 2000-05-02 Pharmasolutions, Inc. Pharmaceutical composition comprising cyclosporin in association with a carrier in a self-emulsifying drug delivery system
GB9912476D0 (en) 1999-05-28 1999-07-28 Novartis Ag Organic compounds
DE19925001A1 (de) * 1999-05-31 2000-12-07 Pharma Concepts Gmbh & Co Kg Flüssiges Konzentrat
US20030236236A1 (en) * 1999-06-30 2003-12-25 Feng-Jing Chen Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
GB2355656B (en) * 1999-08-17 2004-04-07 Galena As Pharmaceutical compositions for oral and topical administration
JP2001122779A (ja) * 1999-10-26 2001-05-08 Toyo Capsule Kk 経口投与用シクロスポリン含有ミクロエマルジョン濃縮液
EP1227793A1 (en) * 1999-11-02 2002-08-07 Cipla Ltd. Cyclosporin formulation
GB2362573A (en) * 2000-05-25 2001-11-28 Cipla Ltd Cyclosporin formulation
US7919113B2 (en) * 1999-12-30 2011-04-05 Yissum Research Development Company Of The Hebrew University Of Jerusalem Dispersible concentrate lipospheres for delivery of active agents
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
US6597932B2 (en) 2000-02-18 2003-07-22 Argose, Inc. Generation of spatially-averaged excitation-emission map in heterogeneous tissue
GB0008785D0 (en) 2000-04-10 2000-05-31 Novartis Ag Organic compounds
DE10029404B4 (de) * 2000-06-15 2009-10-29 Jagotec Ag Arzneiformulierung enthaltend Ciclosporin und deren Verwendung
US6623765B1 (en) * 2000-08-01 2003-09-23 University Of Florida, Research Foundation, Incorporated Microemulsion and micelle systems for solubilizing drugs
US7056530B1 (en) 2000-09-18 2006-06-06 Rpg Life Sciences Ltd. Selfemulsifiable formulation having enhanced bioabsorption and immunosuppression activities
US6960563B2 (en) * 2001-08-31 2005-11-01 Morton Grove Pharmaceuticals, Inc. Spontaneous emulsions containing cyclosporine
US7141648B2 (en) 2001-10-19 2006-11-28 Isotechnika Inc. Synthesis of cyclosporin analogs
CA2461730C (en) 2001-10-19 2012-05-15 Isotechnika Inc. Novel cyclosporin analog microemulsion preconcentrates
HUP0402318A3 (en) 2001-12-14 2012-09-28 Jagotec Ag Pharmaceutical composition comprising cyclosporin and use thereof
BR0215187A (pt) * 2001-12-20 2004-11-16 Bernard Charles Sherman Composições farmacêuticas que compreendem uma ciclosporina, um tensoativo hidrofìlico e um tensoativo lipofìlico
AU2002364212B2 (en) * 2001-12-21 2007-09-20 Shire Laboratories Inc. Oral capsule formulation with increased physical stability
KR100441167B1 (ko) * 2001-12-27 2004-07-21 씨제이 주식회사 마이크로에멀젼 예비 농축액 조성물
US20040005339A1 (en) * 2002-06-28 2004-01-08 Shojaei Amir H. Formulations of fenofibrate and/or fenofibrate derivatives with improved oral bioavailability
KR20040047056A (ko) * 2002-11-29 2004-06-05 한미약품 주식회사 비페닐디메틸디카복실레이트의 경구용 마이크로에멀젼조성물
US6979672B2 (en) 2002-12-20 2005-12-27 Polichem, S.A. Cyclosporin-based pharmaceutical compositions
US20050196370A1 (en) * 2003-03-18 2005-09-08 Zhi-Jian Yu Stable ophthalmic oil-in-water emulsions with sodium hyaluronate for alleviating dry eye
US7181219B2 (en) 2003-05-22 2007-02-20 Lucent Technologies Inc. Wireless handover using anchor termination
GB0320638D0 (en) 2003-09-03 2003-10-01 Novartis Ag Organic compounds
US20050059583A1 (en) * 2003-09-15 2005-03-17 Allergan, Inc. Methods of providing therapeutic effects using cyclosporin components
TW200517114A (en) 2003-10-15 2005-06-01 Combinatorx Inc Methods and reagents for the treatment of immunoinflammatory disorders
US20060003002A1 (en) * 2003-11-03 2006-01-05 Lipocine, Inc. Pharmaceutical compositions with synchronized solubilizer release
RU2006121978A (ru) 2003-11-21 2007-12-27 Комбинаторкс, Инкорпорейтед (Us) Способы и реагенты для лечения воспалительных нарушений
PE20050596A1 (es) * 2003-12-19 2005-10-18 Novartis Ag Microemulsion que comprende un inhibidor renina
IL159729A0 (en) * 2004-01-06 2004-06-20 Doron I Friedman Non-aqueous composition for oral delivery of insoluble bioactive agents
CA2552611A1 (en) * 2004-01-09 2005-08-04 Wyeth Microemulsions for pharmaceutical compositions
JPWO2005089716A1 (ja) * 2004-03-24 2008-01-31 武田薬品工業株式会社 高含量化製剤
WO2005089714A1 (ja) * 2004-03-24 2005-09-29 Takeda Pharmaceutical Company Limited エマルション安定化製剤
CN101065139A (zh) * 2004-10-09 2007-10-31 扶瑞药业股份有限公司 眼用药剂递送系统
US7135455B2 (en) * 2004-11-15 2006-11-14 Allergan, Inc Methods for the therapeutic use of cyclosporine components
US7151085B2 (en) * 2004-11-15 2006-12-19 Allergan, Inc. Therapeutic methods using cyclosporine components
EP1848541A4 (en) * 2005-02-07 2013-01-16 Pharmalight Inc METHOD AND DEVICE FOR THE OPHTHALMIC ADMINISTRATION OF PHARMACEUTICAL ACTIVE SUBSTANCES
GB0504950D0 (en) 2005-03-10 2005-04-20 Novartis Ag Organic compositions
CN101242842A (zh) 2005-06-17 2008-08-13 诺瓦提斯公司 Sanglifehrin在hcv中的用途
US7297679B2 (en) 2005-07-13 2007-11-20 Allergan, Inc. Cyclosporin compositions
US20070015691A1 (en) * 2005-07-13 2007-01-18 Allergan, Inc. Cyclosporin compositions
US7288520B2 (en) 2005-07-13 2007-10-30 Allergan, Inc. Cyclosporin compositions
US7202209B2 (en) * 2005-07-13 2007-04-10 Allergan, Inc. Cyclosporin compositions
US20070015693A1 (en) * 2005-07-13 2007-01-18 Allergan, Inc. Cyclosporin compositions
US7276476B2 (en) * 2005-07-13 2007-10-02 Allergan, Inc. Cyclosporin compositions
US7501393B2 (en) * 2005-07-27 2009-03-10 Allergan, Inc. Pharmaceutical compositions comprising cyclosporins
GT200600411A (es) * 2005-09-13 2007-05-21 Novartis Ag Combinaciones que comprenden un inhibidor del receptor del factor de crecimiento endotelial vascular
US9839667B2 (en) 2005-10-14 2017-12-12 Allergan, Inc. Prevention and treatment of ocular side effects with a cyclosporin
US7745400B2 (en) * 2005-10-14 2010-06-29 Gregg Feinerman Prevention and treatment of ocular side effects with a cyclosporin
US8067433B2 (en) 2005-11-09 2011-11-29 Zalicus Inc. Methods, compositions, and kits for the treatment of ophthalmic disorders
US11311477B2 (en) 2006-03-07 2022-04-26 Sgn Nanopharma Inc. Ophthalmic preparations
US10137083B2 (en) * 2006-03-07 2018-11-27 SGN Nanopharma Inc Ophthalmic preparations
AU2007224006A1 (en) * 2006-03-07 2007-09-13 Novavax, Inc. Nanoemulsions of poorly soluble pharmaceutical active ingredients and methods of making the same
US20070221693A1 (en) * 2006-03-24 2007-09-27 Moore Howard L Multi-purpose insulating and protective cover for containers
ITMI20060618A1 (it) * 2006-03-31 2007-10-01 Enitecnologie Spa Procedimento per la preparazione di nanoemulsioni acqua ion olio e olio in acqua
KR101059593B1 (ko) 2006-04-11 2011-08-25 노파르티스 아게 Ｈｃｖ/ｈｉｖ 억제제 및 이들의 용도
EP2068865A4 (en) * 2006-12-28 2011-08-10 Limerick Biopharma Inc METHOD AND COMPOSITIONS FOR THERAPY TREATMENT
EP2124992A2 (en) 2007-01-04 2009-12-02 Debiopharm S.A. Non-immunosuppressive cyclosporin for treatment of ullrich congenital muscular dystrophy
WO2008122965A2 (en) 2007-04-04 2008-10-16 Sigmoid Pharma Limited Pharmaceutical cyclosporin compositions
JP2010527285A (ja) 2007-04-26 2010-08-12 シグモイド・ファーマ・リミテッド 複数のミニカプセルの製造
JP2011504871A (ja) * 2007-06-01 2011-02-17 ノボ・ノルデイスク・エー／エス 固体又は半固体担体中にペプチド薬剤を含む自然に分散可能なプレコンセントレイト
AU2008282261A1 (en) * 2007-07-31 2009-02-05 Limerick Biopharma, Inc. Phosphorylated pyrone analogs and methods
GB2451811A (en) 2007-08-09 2009-02-18 Ems Sa Delivery composition for solubilising water-insoluble pharmaceutical active ingredients
JP5668476B2 (ja) * 2007-10-08 2015-02-12 オーリニア・ファーマシューティカルズ・インコーポレイテッドＡｕｒｉｎｉａ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃ． カルシニューリン阻害剤またはｍＴＯＲ阻害剤を含む眼科用組成物
BRPI0705564B8 (pt) * 2007-10-10 2021-05-25 Embrapa Pesquisa Agropecuaria sistema do tipo cristal líquido contínuo contendo co-solvente portador de substâncias fracamente solúveis em água, seu processo de obtenção e seus usos
TW200932240A (en) * 2007-10-25 2009-08-01 Astellas Pharma Inc Pharmaceutical composition containing lipophilic substance which inhibits IL-2 production
MX2010009507A (es) * 2008-02-28 2010-09-24 Novartis Ag Combinacion que comprende un compuesto que se enlaza con los receptores de cannabinoides, y un opioide.
WO2009114365A2 (en) * 2008-03-13 2009-09-17 Mallinckrodt Inc. Multi-function, foot-activated controller for imaging system
DE102008015299A1 (de) 2008-03-18 2009-09-24 Pkh Gmbh Halle Kolloidales Trägersystem
PT2910570T (pt) 2008-03-18 2017-01-24 Novo Nordisk As Análogos de insulina acilados, estabilizados contra proteases
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
AU2010203607A1 (en) * 2009-01-08 2011-07-21 Allergan, Inc. Cyclosporine compositions for enhancing nail growth
US20110182850A1 (en) 2009-04-10 2011-07-28 Trixi Brandl Organic compounds and their uses
US8512690B2 (en) 2009-04-10 2013-08-20 Novartis Ag Derivatised proline containing peptide compounds as protease inhibitors
WO2010133609A2 (en) 2009-05-18 2010-11-25 Sigmoid Pharma Limited Composition comprising oil drops
MX338355B (es) * 2009-06-09 2016-04-13 Aurinia Pharmaceuticals Inc Sistemas de suministro de farmaco topico para uso oftalmico.
US9878036B2 (en) 2009-08-12 2018-01-30 Sigmoid Pharma Limited Immunomodulatory compositions comprising a polymer matrix and an oil phase
EP2308468A1 (en) * 2009-10-08 2011-04-13 Novaliq GmbH Novel pharmaceutical composition comprising a macrolide immunosuppressant drug
US8324239B2 (en) 2010-04-21 2012-12-04 Novartis Ag Furopyridine compounds and uses thereof
US20120077778A1 (en) * 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
EA201390532A1 (ru) 2010-10-08 2013-09-30 Новартис Аг Композиции сульфамидых ингибиторов ns3, содержащие витамин е
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
JO3337B1 (ar) 2010-12-13 2019-03-13 Debiopharm Sa تركيبات صيدلية تشمل أليسبوريفير
FR2971941B1 (fr) 2011-02-24 2013-08-02 Physica Pharma Compositions pharmaceutiques administrables par voie cutanee et destinees au traitement local de la dermatite atopique canine
BR112014025132A2 (pt) 2012-04-11 2017-07-11 Novo Nordisk As formulações de insulina
GB201212010D0 (en) 2012-07-05 2012-08-22 Sigmoid Pharma Ltd Formulations
US20140243300A1 (en) * 2013-02-28 2014-08-28 Precision Dermatology, Inc. Controlling the Bioavailability of Active Ingredients in Topical Formulations
GB201319791D0 (en) 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
US20170246187A1 (en) 2014-08-28 2017-08-31 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
WO2016033556A1 (en) 2014-08-28 2016-03-03 Lipocine Inc. BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS
AU2015341695B2 (en) 2014-11-07 2021-07-08 Sublimity Therapeutics Limited Compositions comprising cyclosporin
WO2016205423A2 (en) 2015-06-15 2016-12-22 Lipocine Inc. Composition and method for oral delivery of androgen prodrugs
EP3187172A1 (en) * 2016-01-04 2017-07-05 Spherium Biomed S.L. Cyclosporine a topical compositions
US11559530B2 (en) 2016-11-28 2023-01-24 Lipocine Inc. Oral testosterone undecanoate therapy
PT3554534T (pt) 2016-12-16 2021-11-05 Novo Nordisk As Composições farmacêuticas contendo insulina
US20190224275A1 (en) 2017-05-12 2019-07-25 Aurinia Pharmaceuticals Inc. Protocol for treatment of lupus nephritis
WO2019002362A1 (en) * 2017-06-28 2019-01-03 Spherium Biomed, S.L. TOPICAL COMPOSITIONS OF CYCLOSPORIN A
KR102146704B1 (ko) 2018-04-13 2020-08-21 가천대학교 산학협력단 사이클로스포린 A (CsA) 경피 및 피내 약물전달용 마이크로구조체
US12150945B2 (en) 2018-07-20 2024-11-26 Lipocine Inc. Liver disease
FI3886813T3 (fi) * 2018-11-26 2023-05-04 Hepion Pharmaceuticals Inc Syklosporiinianalogien farmaseuttisia formulaatioita

Family Cites Families (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH246178A (de) * 1942-01-28 1946-12-15 Reichstein Tadeus Dr Prof Verfahren zur Herstellung einer neuen Verbindung der Cyclopentano-polyhydrophenanthrenreihe.
FR1274354A (fr) * 1956-03-10 1961-10-27 Agents tensio-actifs obtenus à partir de triglycérides et polyéthylène glycol
GB1171125A (en) * 1966-06-08 1969-11-19 Glaxo Lab Ltd Improvements in or relating to Injectable Preparations
JPS5114746B1 (enExample) * 1970-12-31 1976-05-12
US3813345A (en) * 1971-08-05 1974-05-28 Vanguard Chem Co Inc Method of producing microcolloidal aqueous emulsions of unsaturated organic compounds
US3954967A (en) * 1971-08-05 1976-05-04 Vanguard Chemical Company, Inc. Method of producing microcolloidal aqueous emulsions of unsaturated organic insecticidal compounds
US4073943A (en) * 1974-09-11 1978-02-14 Apoteksvarucentralen Vitrum Ab Method of enhancing the administration of pharmalogically active agents
US4146499A (en) * 1976-09-18 1979-03-27 Rosano Henri L Method for preparing microemulsions
JPS53107408A (en) * 1977-02-28 1978-09-19 Yamanouchi Pharmaceut Co Ltd Micellar preparation for rectal infusion
CH636013A5 (en) * 1978-03-07 1983-05-13 Sandoz Ag More readily absorbable pharmaceutical composition
SE445174B (sv) * 1978-03-07 1986-06-09 Sandoz Ag Farmaceutisk komposition innehallande en cyklosporin och en berarsubstans
CH641356A5 (en) * 1979-02-27 1984-02-29 Sandoz Ag Pharmaceutical compositions containing cyclosporin
FR2502951B1 (fr) * 1981-04-06 1985-12-06 Sandoz Sa Compositions pharmaceutiques topiques sous forme d'une micro-emulsion
AU558155B2 (en) * 1982-02-01 1987-01-22 Sandoz Ltd. Treating multiple sclerosis with dihydro-cyclosporin d
DE3225706C2 (de) * 1982-07-09 1984-04-26 A. Nattermann & Cie GmbH, 5000 Köln Flüssige Wirkstofformulierungen in Form von Konzentraten für Mikroemulsionen
DE3235612A1 (de) * 1982-09-25 1984-03-29 Bayer Ag, 5090 Leverkusen Mikroemulsionen
DE3237814A1 (de) * 1982-10-12 1984-04-12 Warner-Lambert Co., 07950 Morris Plains, N.J. Wasserfreie emulsionen und verwendung derselben
DE3315805A1 (de) * 1983-04-30 1984-11-08 Bayer Ag, 5090 Leverkusen Wirkstoffzubereitungen
JPS6024776A (ja) * 1983-07-19 1985-02-07 Fujitsu Ltd 中間調画像圧縮方式
JPS6061535A (ja) * 1983-08-24 1985-04-09 エフ・ホフマン・ラ・ロシユ・ウント・コンパニ−・アクチエンゲゼルシヤフト 製薬学的組成物
FR2553661B1 (fr) * 1983-10-19 1985-12-20 Rhone Poulenc Sante Nouvelles microemulsions pharmaceutiquement acceptables
DE3406497A1 (de) * 1984-02-23 1985-09-05 Mueller Bernhard Willi Werner Hochdisperse pharmazeutische mehrkomponentensysteme und verfahren zu ihrer herstellung
US4605422A (en) * 1984-03-30 1986-08-12 Union Carbide Corporation Oil-in-alcohol microemulsion
US4794000A (en) * 1987-01-08 1988-12-27 Synthetic Blood Corporation Coacervate-based oral delivery system for medically useful compositions
US4963367A (en) * 1984-04-27 1990-10-16 Medaphore, Inc. Drug delivery compositions and methods
US5639724A (en) * 1984-07-24 1997-06-17 Sandoz Ltd. Cyclosporin galenic forms
EP0170623B1 (en) * 1984-08-02 1990-11-28 Sandoz Ag Novel pharmaceutical use of (nva)2-cyclosporine
CH662944A5 (it) * 1984-10-18 1987-11-13 Pier Luigi Prof Dr Luisi Procedimento per la preparazione di biocompatibili di micelle inverse di biocompatibili e loro utilizzazione.
JPS61280435A (ja) * 1985-04-04 1986-12-11 Kanji Takada サイクロスポリン類のリンパ指向性製剤
JPS61249918A (ja) * 1985-04-26 1986-11-07 Yutaka Mizushima 点眼剤
IL78929A0 (en) * 1985-07-29 1986-09-30 Abbott Lab Microemulsion compositions for parenteral administration
US5023271A (en) * 1985-08-13 1991-06-11 California Biotechnology Inc. Pharmaceutical microemulsions
US4797272A (en) * 1985-11-15 1989-01-10 Eli Lilly And Company Water-in-oil microemulsions for cosmetic uses
SE8601624D0 (sv) * 1986-04-11 1986-04-11 Haessle Ab New pharmaceutical preparations
SE457693B (sv) * 1986-07-01 1989-01-23 Drilletten Ab Komposition med reglerad frigoering vari ett biologiskt material aer loest eller dispergerat i en l2-fas
CA1318589C (en) * 1986-08-14 1993-06-01 Bernard Ecanow Drug delivery system
DE3629386A1 (de) * 1986-08-29 1988-03-03 Scherer Gmbh R P Gelatinekapseln und verfahren zu ihrer herstellung
HU205861B (en) * 1986-12-19 1992-07-28 Sandoz Ag Process for producing hydrosole of pharmaceutically effective material
DE3707711A1 (de) * 1987-03-11 1988-09-22 Hoechst Ag Oel-in-wasser-emulsionen, verfahren zu deren herstellung und deren verwendung
CA1301642C (en) * 1987-03-30 1992-05-26 Howard Bernard Dawson Chemical formulations
US4798823A (en) * 1987-06-03 1989-01-17 Merck & Co., Inc. New cyclosporin analogs with modified "C-9 amino acids"
DE3884470T2 (de) * 1987-06-17 1994-03-10 Sandoz Ag Cyclosporine und deren Benutzung als Arzneimittel.
GB2206119B (en) * 1987-06-22 1990-10-31 Merck & Co Inc A new cyclosporin derivative with modified "8-amino acid"
US4835002A (en) * 1987-07-10 1989-05-30 Wolf Peter A Microemulsions of oil in water and alcohol
HU205010B (en) * 1987-09-15 1992-03-30 Sandoz Ag Process for producing pharmaceutical compositions comprising compounds soluble up to 1 per cent and having medical activity
DK483587D0 (da) * 1987-09-15 1987-09-15 Riemann & Co Aps Claus Antiperspirant praeparat
US5756450A (en) * 1987-09-15 1998-05-26 Novartis Corporation Water soluble monoesters as solubilisers for pharmacologically active compounds and pharmaceutical excipients and novel cyclosporin galenic forms
IL88076A (en) * 1987-10-28 1993-01-14 Nippon Shinyaku Co Ltd Fat emulsions as drug carriers
US4914188A (en) * 1987-11-16 1990-04-03 Merck & Co., Inc. Novel 6-position cyclosporin analogs as non-immunosuppressive antagonists of cyclosporin binding to cyclophilin
HU203564B (en) * 1987-12-21 1991-08-28 Sandoz Ag Process for producing new orthorombos cyclosporin without solvatation
EP0327280B1 (en) * 1988-01-29 1992-03-18 Sankyo Company Limited Cyclosporin compositions
JPH01249918A (ja) * 1988-03-30 1989-10-05 Kubota Ltd 強制送風式エンジンの放熱器の防塵装置
CH679119A5 (enExample) * 1988-05-13 1991-12-31 Sandoz Ag
HU201567B (en) * 1988-07-21 1990-11-28 Gyogyszerkutato Intezet Process for production of intravenous medical compositions containing cyclosphorin
KR0148748B1 (ko) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
US5342625A (en) * 1988-09-16 1994-08-30 Sandoz Ltd. Pharmaceutical compositions comprising cyclosporins
CH679210A5 (enExample) * 1988-10-26 1992-01-15 Sandoz Ag
FR2642650B1 (fr) * 1989-02-09 1994-12-09 Sandoz Sa Nouvelles compositions pharmaceutiques a base de cyclosporines
US4996193A (en) * 1989-03-03 1991-02-26 The Regents Of The University Of California Combined topical and systemic method of administration of cyclosporine
GB9208712D0 (en) * 1992-04-22 1992-06-10 Sandoz Ltd Pharmaceutical compositions containing cyclosporin derivates

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100894130B1 (ko) * 1988-09-16 2009-04-20 노바티스 아게 사이클로스포린을 함유하는 약학 조성물
WO2004073693A1 (en) * 2003-02-19 2004-09-02 Korea United Pharm, Inc. Soft capsule containing cyclosporine and it's manufacturing process
WO2013055073A3 (ko) * 2011-10-10 2013-07-04 Kim Yong Nam 사이클로스포린 함유 안약 조성물 및 그 제조방법

Also Published As

Publication number Publication date
IE892939L (en) 1990-03-16
BG60525B2 (bg) 1995-07-28
PH31059A (en) 1998-02-05
JPH02121929A (ja) 1990-05-09
GB2222770B (en) 1992-07-29
DK455989D0 (da) 1989-09-15
IT1232243B (it) 1992-01-28
GR1000456B (el) 1992-07-30
HK86593A (en) 1993-08-27
FI894342L (fi) 1990-03-17
ES2020738A6 (es) 1991-09-16
JPH0725690B2 (ja) 1995-03-22
MY107381A (en) 1995-11-30
SE8903042D0 (sv) 1989-09-15
SE8903042L (sv) 1990-05-11
NZ230660A (en) 1992-06-25
GB8920597D0 (en) 1989-10-25
IL91642A0 (en) 1990-04-29
SG50793G (en) 1993-06-25
FI98046C (fi) 1997-04-10
KR20070108289A (ko) 2007-11-09
NO893678D0 (no) 1989-09-14
FI98046B (fi) 1996-12-31
US6024978A (en) 2000-02-15
AT403435B (de) 1998-02-25
US5866159A (en) 1999-02-02
KR100446170B1 (ko) 2004-11-20
US7235248B2 (en) 2007-06-26
AU4140089A (en) 1990-03-22
ID17863A (id) 1998-01-29
FR2636534B1 (fr) 1994-09-09
ATA214289A (de) 1997-07-15
DE3930928A1 (de) 1990-03-22
KR900004348A (ko) 1990-04-12
US5962014A (en) 1999-10-05
US5962017A (en) 1999-10-05
US20030143250A1 (en) 2003-07-31
BE1003105A5 (fr) 1991-11-26
PT91731A (pt) 1990-03-30
FR2636534A1 (fr) 1990-03-23
LV5749A4 (lv) 1996-12-20
NL194781C (nl) 2003-03-04
PT91731B (pt) 1995-08-09
KR100894130B1 (ko) 2009-04-20
CA1332150C (en) 1994-09-27
IL91642A (en) 1994-04-12
IE60764B1 (en) 1994-08-10
IT8948369A0 (it) 1989-09-15
GR890100583A (en) 1990-10-31
DE3930928C2 (de) 1994-06-01
AU627220B2 (en) 1992-08-20
HU211685A9 (en) 1995-12-28
US5916589A (en) 1999-06-29
NO180362B (no) 1996-12-30
FI894342A0 (fi) 1989-09-14
LV5749B4 (lv) 1997-04-20
DK455989A (da) 1990-03-17
NO893678L (no) 1990-03-19
NL8902315A (nl) 1990-04-17
CH679118A5 (enExample) 1991-12-31
US5741512A (en) 1998-04-21
LU87586A1 (fr) 1991-05-07
GB2222770A (en) 1990-03-21
DK171433B1 (da) 1996-10-28
NO180362C (no) 1997-04-09
NL194781B (nl) 2002-11-01
SE514303C2 (sv) 2001-02-05

Similar Documents

Publication Publication Date Title
KR0148748B1 (ko) 사이클로스포린을 함유하는 약학조성물
US5342625A (en) Pharmaceutical compositions comprising cyclosporins
US6007840A (en) Pharmaceutical compositions comprising cyclosporins
JP4073641B2 (ja) 新規シクロスポリン製剤
US5843891A (en) Pharmaceutical acceptable compositions containing an alcohol and a hydrophobic drug
NZ243309A (en) Pharmaceutical composition containing a cyclosporin, a surfactant, a mixed mono-, di-, and tri-glyceride, and 1,2-propylene glycol
KR100267149B1 (ko) 사이클로스포린을 함유하는 약학 조성물
KR100256007B1 (ko) 사이클로스포린을 함유하는 약학 조성물
CY1711A (en) Pharmaceutical compositions containing cyclosporins
HU212727B (en) Process for producing pharmaceutical compositions in form of microemulsion-prae-concentrate or microemulsion containing cyclosporin(s) as active component

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19890912

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19930702

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 19890912

Comment text: Patent Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 19970120

Patent event code: PE09021S01D

AMND Amendment
E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 19970617

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 19970120

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

J2X1 Appeal (before the patent court)

Free format text: APPEAL AGAINST DECISION TO DECLINE REFUSAL

Free format text: TRIAL NUMBER: 1997201002132; APPEAL AGAINST DECISION TO DECLINE REFUSAL

PJ2001 Appeal

Appeal kind category: Appeal against decision to decline refusal

Decision date: 19980309

Appeal identifier: 1997201002132

Request date: 19970918

PB0901 Examination by re-examination before a trial

Comment text: Request for Trial against Decision on Refusal

Patent event date: 19970918

Patent event code: PB09011R01I

Comment text: Amendment to Specification, etc.

Patent event date: 19970329

Patent event code: PB09011R02I

B701 Decision to grant
PB0701 Decision of registration after re-examination before a trial

Patent event date: 19980309

Comment text: Decision to Grant Registration

Patent event code: PB07012S01D

Patent event date: 19980209

Comment text: Transfer of Trial File for Re-examination before a Trial

Patent event code: PB07011S01I

N231 Notification of change of applicant
PN2301 Change of applicant

Patent event date: 19980311

Comment text: Notification of Change of Applicant

Patent event code: PN23011R01D

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 19980529

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 19980529

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
J206 Request for trial to confirm the scope of a patent right
PJ0206 Trial to confirm the scope of a patent

Patent event code: PJ02062R01D

Patent event date: 19990929

Comment text: Request for Trial

Patent event code: PJ02061E01I

Patent event date: 19980529

Comment text: Registration of Establishment

Decision date: 20011031

Request date: 19990929

Appeal identifier: 1999100001721

Appeal kind category: Confirmation of the scope of right_defensive

J204 Request for invalidation trial [patent]
PJ0204 Invalidation trial for patent

Patent event date: 20001013

Comment text: Request for Trial

Patent event code: PJ02042R01D

Patent event date: 19980529

Comment text: Registration of Establishment

Patent event code: PJ02041E01I

Appeal kind category: Invalidation

Request date: 20001013

Decision date: 20011228

Appeal identifier: 2000100001652

PR1001 Payment of annual fee

Payment date: 20010418

Start annual number: 4

End annual number: 4

J301 Trial decision

Free format text: TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 19990929

Effective date: 20011031

Free format text: TRIAL NUMBER: 1999100001721; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 19990929

Effective date: 20011031

PJ1301 Trial decision

Patent event code: PJ13011S01D

Patent event date: 20011101

Comment text: Trial Decision on Objection to Decision on Refusal

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 19990929

Decision date: 20011031

Appeal identifier: 1999100001721

J2X1 Appeal (before the patent court)

Free format text: CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE

Free format text: TRIAL NUMBER: 2001200006827; CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE

PJ2001 Appeal

Patent event date: 20011101

Comment text: Trial Decision on Objection to Decision on Refusal

Patent event code: PJ20011S01I

Appeal kind category: Confirmation of the scope of right_defensive

Decision date: 20030523

Appeal identifier: 2001200006827

Request date: 20011205

J301 Trial decision

Free format text: TRIAL DECISION FOR INVALIDATION REQUESTED 20001013

Effective date: 20011228

Free format text: TRIAL NUMBER: 2000100001652; TRIAL DECISION FOR INVALIDATION REQUESTED 20001013

Effective date: 20011228

PJ1301 Trial decision

Patent event code: PJ13011S01D

Patent event date: 20020102

Comment text: Trial Decision on Objection to Decision on Refusal

Appeal kind category: Invalidation

Request date: 20001013

Decision date: 20011228

Appeal identifier: 2000100001652

J2X1 Appeal (before the patent court)

Free format text: INVALIDATION

Free format text: TRIAL NUMBER: 2002200000840; INVALIDATION

PJ2001 Appeal

Patent event date: 20020102

Comment text: Trial Decision on Objection to Decision on Refusal

Patent event code: PJ20011S01I

Patent event date: 20011101

Comment text: Trial Decision on Objection to Decision on Refusal

Patent event code: PJ20011S01I

Appeal kind category: Invalidation

Decision date: 20030523

Appeal identifier: 2002200000840

Request date: 20020202

PR1001 Payment of annual fee

Payment date: 20020404

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 20030424

Start annual number: 6

End annual number: 6

J2X2 Appeal (before the supreme court)

Free format text: APPEAL BEFORE THE SUPREME COURT FOR INVALIDATION

Free format text: TRIAL NUMBER: 2003300001390; APPEAL BEFORE THE SUPREME COURT FOR INVALIDATION

PJ2002 Appeal before the supreme court

Comment text: Trial Decision on Objection to Decision on Refusal

Patent event date: 20020102

Patent event code: PJ20021S01I

Comment text: Trial Decision on Objection to Decision on Refusal

Patent event date: 20011101

Patent event code: PJ20021S01I

Request date: 20030612

Appeal identifier: 2003300001390

Appeal kind category: Invalidation

Decision date: 20040227

J302 Written judgement (patent court)

Free format text: JUDGMENT (PATENT COURT) FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20011205

Effective date: 20030523

Free format text: TRIAL NUMBER: 2001200006827; JUDGMENT (PATENT COURT) FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20011205

Effective date: 20030523

PJ1302 Judgment (patent court)

Patent event date: 20030621

Comment text: Written Judgment (Patent Court)

Patent event code: PJ13021S01D

Request date: 20011205

Decision date: 20030523

Appeal identifier: 2001200006827

Appeal kind category: Confirmation of the scope of right_defensive

PJ2201 Remand (intellectual property tribunal)

Patent event code: PJ22012S01I

Comment text: Written Judgment (Patent Court)

Patent event date: 20030621

Request date: 20030621

Appeal kind category: Confirmation of the scope of right_defensive

Appeal identifier: 2003130000070

Decision date: 20030830

J301 Trial decision

Free format text: TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20030621

Effective date: 20030830

Free format text: TRIAL NUMBER: 2003130000070; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20030621

Effective date: 20030830

PJ1301 Trial decision

Patent event code: PJ13011S09D

Patent event date: 20030830

Comment text: Trial Decision on Final Judgment on Revocation

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20030621

Decision date: 20030830

Appeal identifier: 2003130000070

J302 Written judgement (patent court)

Free format text: JUDGMENT (PATENT COURT) FOR INVALIDATION REQUESTED 20020202

Effective date: 20030523

Free format text: TRIAL NUMBER: 2002200000840; JUDGMENT (PATENT COURT) FOR INVALIDATION REQUESTED 20020202

Effective date: 20030523

J303 Written judgement (supreme court)

Free format text: JUDGMENT (SUPREME COURT) FOR INVALIDATION REQUESTED 20030612

Effective date: 20040227

Free format text: TRIAL NUMBER: 2003300001390; JUDGMENT (SUPREME COURT) FOR INVALIDATION REQUESTED 20030612

Effective date: 20040227

PJ1302 Judgment (patent court)

Patent event date: 20040313

Comment text: Written Judgment (Patent Court)

Patent event code: PJ13021S01D

Request date: 20020202

Decision date: 20030523

Appeal identifier: 2002200000840

Appeal kind category: Invalidation

PJ1303 Judgment (supreme court)

Comment text: Written Judgment (Supreme Court)

Patent event date: 20040313

Patent event code: PJ13031S01D

Decision date: 20040227

Appeal kind category: Invalidation

Request date: 20030612

Appeal identifier: 2003300001390

PR1001 Payment of annual fee

Payment date: 20040419

Start annual number: 7

End annual number: 7

PR1001 Payment of annual fee

Payment date: 20050331

Start annual number: 8

End annual number: 8

PR1001 Payment of annual fee

Payment date: 20060404

Start annual number: 9

End annual number: 9

PR1001 Payment of annual fee

Payment date: 20070523

Start annual number: 10

End annual number: 10

PR1001 Payment of annual fee

Payment date: 20080522

Start annual number: 11

End annual number: 11

PR1001 Payment of annual fee

Payment date: 20090525

Start annual number: 12

End annual number: 12

PR1001 Payment of annual fee

Payment date: 20100525

Start annual number: 13

End annual number: 13

PR1001 Payment of annual fee

Payment date: 20110421

Start annual number: 14

End annual number: 14

FPAY Annual fee payment

Payment date: 20120503

Year of fee payment: 15

PR1001 Payment of annual fee

Payment date: 20120503

Start annual number: 15

End annual number: 15

EXPY Expiration of term
PC1801 Expiration of term

Termination date: 20131129

Termination category: Expiration of duration